Navigation Links
Cardiologists and heart surgeons meet for 'Controversies and Advances' conference
Date:9/26/2007

Marbn came to Cedars-Sinai to serve as the first director of the Heart Institute, which integrates and oversees the development of programs in cardiology, cardiac surgery, cardiac imaging and other areas. He has received funding to support three clinical studies reintroducing cardiac stem cells into heart patients, with first enrollment anticipated early next year.

Additional keynote speakers will include Dr. Jack Lewin, CEO American College of Cardiology, who will speak on healthcare reform.

Program directors for Controversies and Advances in the Treatment of Cardiovascular Disease include: Gregory P. Fontana, M.D., cardiothoracic surgeon and vice chairman of Surgery; Raj Makkar, M.D., cardiologist and director, Interventional Cardiology; P.K. Shah, M.D., cardiologist and director of the Division of Cardiology; Alfredo Trento, M.D., cardiothoracic surgeon and director of the Division of Cardiothoracic Surgery at Cedars-Sinai; and John G. Harold, M.D., FACC, cardiologist and President, California Chapter American College of Cardiology (ACC), ACC Governor for Southern California, and a recent Chief of Staff at Cedars-Sinai.

Sessions on Thursday, Oct. 4, will address coronary artery disease (part 1), mitral valve and carotid artery disease, arrhythmias and atrial fibrillation, and the future and new techniques. Fridays sessions look at coronary artery disease (part 2), aortic valve disease, congenital heart disease, and surgery and interventional cardiology. Several lectures and/or debates will be presented on each subject.


'/>"/>

Contact: Sandy Van
sandy@prpacific.com
800-880-2397
Cedars-Sinai Medical Center
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology news :

1. HIV Patients May Be at Risk of Heart Problems When Taking Protease Inhibitor Drugs
2. UCSD team discovers specialized, rare heart stem cells in newborns
3. Implanted Devices Detect High-Risk Heart Failure Patients
4. Rush Physicians Using Gene Therapy For Heart Patients With Moderate To Severe Chest Pains Who Do Not Benefit From Other Treatments
5. Special Imaging Study Shows Failing Hearts Are Energy Starved
6. Stem Cell Research Shows Potential for Replacing Tissue Damaged in Heart Attacks
7. Single stem cells from bone heal a broken heart
8. Heart repair gets new muscle
9. Python a hearty eater
10. Columbia study shows widely used artery clearing device does not help patients during heart attack
11. Researchers reveal secret of key protein in brain and heart function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2008)...l crime, treating an ageing population, and turnin...e focus of a 20 million ($30.4 million) investment...ciences Research Council (EPSRC), Technology Strat...al Sciences Research Council (BBSRC). , This new...here world-class scientific breakthroughs have alr...
(Date:11/19/2008)...t. Jude Children,s Research Hospital have gained n...nzyme workhorses called calpains. , As the cell...any cellular processes, including the movement of ...lin secretion, and brain cell and muscle function....s is that defective or overactive calpains have be...
(Date:11/19/2008)...8 -- From dolphins to clams to flying creatures li...scinating creatures exhibit forms of fluid flow. W...al Society (APS) Division of Fluid Dynamics takes ...ntion Center, researchers from across the globe wi...s in astronomy, engineering, alternative energy, b...
(Date:11/19/2008)...VEMBER 17, 2008 -- One of the biggest threats to t...n (SOC) and soil organic matter (SOM) from poor la...erials is essential as they do everything from pro...armful chemical compounds to the prevention of soi...op residues are critical for maintaining soil prod...
Breaking Biology News(10 mins):£20 million to fight virtual crime and treat our ageing population 2£20 million to fight virtual crime and treat our ageing population 3New insight into the controls on a go-to enzyme 2New insight into the controls on a go-to enzyme 3Animal and biological science highlights: San Antonio Fluid Dynamics Conference, Nov. 23-25 2Animal and biological science highlights: San Antonio Fluid Dynamics Conference, Nov. 23-25 3Animal and biological science highlights: San Antonio Fluid Dynamics Conference, Nov. 23-25 4Animal and biological science highlights: San Antonio Fluid Dynamics Conference, Nov. 23-25 5Animal and biological science highlights: San Antonio Fluid Dynamics Conference, Nov. 23-25 6Animal and biological science highlights: San Antonio Fluid Dynamics Conference, Nov. 23-25 7Animal and biological science highlights: San Antonio Fluid Dynamics Conference, Nov. 23-25 8A model to measure soil health in the era of bioenergy 2Stereotaxis to Present at the Deutsche Bank 33rd Annual Health Care Conference 18235 1ACC Observes National Drinking Water Week 18231 1ACC Observes National Drinking Water Week 18231 2HER1 and HER3 VeraTag 28TM 29 Assays are Now Available for Use in Development and Clinical Evaluation of Cancer Therapeutics 5053 1HER1 and HER3 VeraTag 28TM 29 Assays are Now Available for Use in Development and Clinical Evaluation of Cancer Therapeutics 5053 2HER1 and HER3 VeraTag 28TM 29 Assays are Now Available for Use in Development and Clinical Evaluation of Cancer Therapeutics 5053 3HER1 and HER3 VeraTag 28TM 29 Assays are Now Available for Use in Development and Clinical Evaluation of Cancer Therapeutics 5053 4HER1 and HER3 VeraTag 28TM 29 Assays are Now Available for Use in Development and Clinical Evaluation of Cancer Therapeutics 5053 5United Therapeutics Announces the Results of Its 2008 Annual Meeting of Shareholders 5049 1United Therapeutics Announces the Results of Its 2008 Annual Meeting of Shareholders 5049 2United Therapeutics Announces the Results of Its 2008 Annual Meeting of Shareholders 5049 3
... Affymetrix and Stratagene announced today tha... alliance under which Stratagene will provide Affy...eneChip(R) data analysis. As part of this agreemen...for Affymetrix, ArrayAssist(R) Lite, which will be...on of Affymetrix gene expression microarrays. , In...
... The Food and Drug Administration (FDA) today appr...od sugar for adults with type 1 and type 2 diabete...rapy in patients who cannot achieve adequate contr...apy alone. , Symlin will be the only therapy for t.... Patients with type 2 diabetes already have sever...
... It seems survival of the fittest affect every or...ry Monarchs seem more resistant than non-migratory...vered why it is so. Explanation : infected monarch...es, so they can,t propagate the infection once arr...of animal migration is whether these long journeys...
... In a first, Carnegie Mellon University scientists...t agents, enabling unprecedented high-resolution, ...s, appearing in the April issue of Nature Medicine...ical studies in the emerging field of molecular th...apeutic genes in patients. , "For 20 years it has ...
Other Biology News:Affymetrix and Stratagene Announce Strategic Software Alliance 2FDA Approves New Drug to Treat Type I and Type II Diabetes 2Carnegie Mellon scientists develop tool that uses MRI to visualize gene expression in living animals 2
(Date:11/20/2008)...LIFF LAKE, N.J., Nov. 20 ... today announced that the U.S. District Court for ...aZeneca Pharmaceuticals, motion for a temporary re...ric Pulmicort Respules(R) (budesonide inhaled solu...nst Teva, AstraZeneca agreed and that it too would...
(Date:11/20/2008)...ON, N.J., Nov. 20 At a m... WYE ), held today, a dividend of fifty cents($0....ed Stock was declared,payable on January 2, 2009 ...,on December 12, 2008. , Wyeth is one of t...and,health care products companies. It is a lead...
(Date:11/20/2008)...OUIS, Nov. 20 Sigma-Aldr...release of MISSION(R) In VIVO QUALITY and iScale,...Scale Oligos(TM) siRNA are,expected to allow rese...r RNAi,research with the highest purity and quali...els. These siRNA are believed to be well suited to...
(Date:11/20/2008)...ORK, Nov. 20 Nephros, In...ping and marketing filtration products for therape...rification, today provided an update on its operat...nd Events , , , , Appointed Ja... Appointed Ernest Elgin III President and CE...
Breaking Biology Technology:Par Pharmaceutical Halts Shipment of Budesonide Inhalation Suspension 2Sigma-Aldrich Introduces MISSION(R) In VIVO QUALITY and iScale Oligos(TM) siRNA, a Superior Quality siRNA Designed for RNAi Research in Animal Models 2Nephros Provides Corporate Update 2Nephros Provides Corporate Update 3Nephros Provides Corporate Update 4Nephros Provides Corporate Update 5Nephros Provides Corporate Update 6Nephros Provides Corporate Update 7
... cleanup of DNA from PCR or other enzymatic , ... Application: , PCR cleanup, ...t: , Spin columns, , ...s, , , DNA size ran... , Equipment required: , ...
... purification of PCR products in low elution , ... Application: , PCR product clean... Format: , Spin columns, , ... samples, , , DNA s... , Equipment required: , ...
...Ni-NTA Superflow Columns enable up to 24 automated...tions to be performed in parallel on the BioRobot ...rom bacterial cultures as starting material, , ... under native or denaturing , conditions us...means that , more experiments can be perfor...
...&D Department , QIAGEN GmbH, Hilden, Germa...ion profiling at the RNA level has been significan...d quantitative real-time RT-PCR. Microarray analys...ession levels of hundreds or thousands , of...n. Although real-time , PCR analysis provid...
Other Biology Technology:Ni-NTA Superflow Columns - automated large-scale purification of 6xHis-tagged , proteins 2Ni-NTA Superflow Columns - automated large-scale purification of 6xHis-tagged , proteins 3Ni-NTA Superflow Columns - automated large-scale purification of 6xHis-tagged , proteins 4Critical factors for successful microarray and real-time PCR analyses 2Critical factors for successful microarray and real-time PCR analyses 3Critical factors for successful microarray and real-time PCR analyses 4Critical factors for successful microarray and real-time PCR analyses 5Critical factors for successful microarray and real-time PCR analyses 6Critical factors for successful microarray and real-time PCR analyses 7Critical factors for successful microarray and real-time PCR analyses 8
Polyclonal Antibody against Nonmuscle Myosin II Heavy Chain Isoform B Affinity Purified Antibody (Stored in TBS + 0.03% Thimerosal) This antibody was raised against the peptide SDVNETQPPQSE correspon
Anti-Lipid Phosphate Phosphatase 2 (LPP2) fractionated antiserum buffered aqueous solution Solution in phosphate buffered saline containing 0.08% sodium azide. unique peptide derived from the human
Goat polyclonal to Synaptogyrin 2 ( Abpromise for all tested applications). Antigen: Synthetic peptide: CIYGEGYSNAHESKQ, corresponding to Internal sequence amino acids 42-57 of Human Synaptogyri
Goat polyclonal to Centaurin alpha 2**
Biology Products: